Valerian for insomnia: A systematic review of randomized clinical trials

170Citations
Citations of this article
127Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: To systematically review the evidence for the effects of the herb valerian (Valeriana officinalis) on insomnia, based on randomized, placebo-controlled, double-blind trials. Background: Valerian has long been advocated and used for promoting sleep but until quite recently evidence was solely anecdotal. However, during the last two decades a number of clinical trials have been conducted. Materials and methods: Systematic literature searches were performed to locate randomized, placebo-controlled, double-blind trials measuring the effect of valerian monopreparations on sleep in human participants. Data were extracted in a standardized manner and methodological quality was assessed by the Jadad score. Results: Nine trials were located meeting the selection criteria. The findings of the studies were contradictory and there was great inconsistency between trials in terms of patients, experimental design and procedures and methodological quality. Conclusion: The evidence for valerian as a treatment for insomnia is inconclusive. There is a need for rigorous trials to determine its efficacy. © 2000 Elsevier Science B.V.

Cite

CITATION STYLE

APA

Stevinson, C., & Ernst, E. (2000). Valerian for insomnia: A systematic review of randomized clinical trials. Sleep Medicine, 1(2), 91–99. https://doi.org/10.1016/s1389-9457(99)00015-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free